Literature DB >> 26812453

A Review of Cardiorespiratory Fitness in Adolescent and Young Adult Survivors of Childhood Cancer: Factors that Affect its Decline and Opportunities for Intervention.

Amy M Berkman1, Susan G Lakoski2.   

Abstract

Childhood cancer incidence and survivorship rates are increasing, leading to a growing population of survivors that are at risk for competing causes of death, most notably cardiovascular disease (CVD). Cardiorespiratory fitness (CRF), a key modifiable CVD risk factor, is lower than expected among childhood survivors 5-20 years post-diagnosis. This review discusses the studies that demonstrate lower CRF in survivors of childhood cancer and the potential mechanisms and factors contributing to lower CRF in this population. Both exercise interventions and strategies to improve CRF are considered. The review advocates for more robust clinical research and exercise interventions to improve CRF with the goal of reducing comorbidities and competing CVD risk among childhood cancer survivors into adolescence and young adulthood.

Entities:  

Keywords:  adolescent cancer; cardiorespiratory fitness; childhood cancer; young adult cancer

Mesh:

Year:  2015        PMID: 26812453     DOI: 10.1089/jayao.2015.0031

Source DB:  PubMed          Journal:  J Adolesc Young Adult Oncol        ISSN: 2156-5333            Impact factor:   2.223


  7 in total

1.  Short and long-term impairments of cardiopulmonary fitness level in previous childhood cancer cases: a systematic review.

Authors:  Vesile Yildiz Kabak; Patrick Calders; Tulin Duger; Jibril Mohammed; Eric van Breda
Journal:  Support Care Cancer       Date:  2018-09-25       Impact factor: 3.603

2.  The 6-minute walk test is a good predictor of cardiorespiratory fitness in childhood cancer survivors when access to comprehensive testing is limited.

Authors:  David Mizrahi; Joanna E Fardell; Richard J Cohn; Robyn E Partin; Carrie R Howell; Melissa M Hudson; Leslie L Robison; Kirsten K Ness; Jamie McBride; Penelope Field; Claire E Wakefield; David Simar
Journal:  Int J Cancer       Date:  2019-12-17       Impact factor: 7.396

3.  Multimorbidity patterns and risk of hospitalisation in children: A population cohort study of 3.6 million children in England, with illustrative examples from childhood cancer survivors.

Authors:  Sheng-Chia Chung; Stefanie Mueller; Katherine Green; Wai Hoong Chang; Darren Hargrave; Alvina G Lai
Journal:  Lancet Reg Health Eur       Date:  2022-06-30

4.  Interactive Video Games as a Method to Increase Physical Activity Levels in Children Treated for Leukemia.

Authors:  Aleksandra Kowaluk; Marek Woźniewski
Journal:  Healthcare (Basel)       Date:  2022-04-06

5.  A partially supervised physical activity program for adult and adolescent survivors of childhood cancer (SURfit): study design of a randomized controlled trial [NCT02730767].

Authors:  Corina S Rueegg; Susi Kriemler; Simeon J Zuercher; Christina Schindera; Andrea Renner; Helge Hebestreit; Christian Meier; Prisca Eser; Nicolas X von der Weid
Journal:  BMC Cancer       Date:  2017-12-05       Impact factor: 4.430

6.  The Physical Activity and Fitness in Childhood Cancer Survivors (PACCS) Study: Protocol for an International Mixed Methods Study.

Authors:  Hanne C Lie; Sigmund Anderssen; Corina Silvia Rueegg; Truls Raastad; May Grydeland; Lene Thorsen; Trine Stensrud; Elisabeth Edvardsen; Marie Hamilton Larsen; Ingrid Kristin Torsvik; Lars Peder Bovim; Miriam Götte; Päivi Maria Lähteenmäki; Susi Kriemler; Hanne Bækgaard Larsen; Martin Kaj Fridh; Kristin Ørstavik; Henrik Brun; Iren Matthews; Else Hornset; Ellen Ruud
Journal:  JMIR Res Protoc       Date:  2022-03-08

7.  Device-measured physical activity and cardiovascular disease risk in adolescent childhood cancer survivors. A physical activity in childhood cancer survivors (PACCS) study.

Authors:  Mari Bratteteig; Sigmund Alfred Anderssen; Corina Silvia Rueegg; Ellen Ruud; Ingrid Kristin Torsvik; Susi Kriemler; May Grydeland
Journal:  Front Pediatr       Date:  2022-08-25       Impact factor: 3.569

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.